Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

¥9.44As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002399Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (5.67%)
Div yield 1.54%
ROE 1.50%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM 72.96
TSR TTM (21.11%)
Mkt cap ¥12.53B
ROIC 4.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
19.54%
(66.77%)
Hold 5|12|10|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.19
0.18
0.20
19.86%
24.21%
16.46%
19.02%
Revenue¥M
733.0
745.8
776.5
772.4
6.42%
10.00%
12.31%
7.14%
Peers (US$1.879B)
Cap (US$)
PE
1.926B
13.11x
1.907B
—
1.816B
19.49x
Capital
TTM
5Y
10Y
Leveragex
1.314
—
—
EBIT/Intx
0.416
0.349
0.342
Own earn%
54.19
(133.91)
(109.05)
Sh yield%
29.14
39.70
42.81
Owners
Insiders/Inst%
12.63
81.30
Short interest%
3.80
SBC / revenue%
2.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
6–18
$1 testx
0.0
Incr. ROIC%
14